06:05 EST Autolus Therapeutics files automatic mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AUTL:
- BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
- Autolus Therapeutics’ CAR T Therapy FDA Application Accepted
- Autolus Therapeutics announces publication in ACS Chemical Biology
- Autolus Therapeutics announces acceptance of Biologics License Application for obecabtagene autoleucel (obe-cel) as a potential treatment for relapsed/refractory Adult B-cell Acute Lymphoblastic Leukemia (ALL)
- Autolus Therapeutics announces acceptance of BLA for obe-cel